Abstract

Background and AimsNonalcoholic fatty liver disease (NALFD) is a leading cause of liver disease. Weight loss improves clinical features of NAFLD; however, maintenance of weight loss outside of investigational protocols is poor. The goals of this study were to characterize patterns and clinical predictors of long-term weight loss in ambulatory patients with NAFLD.MethodsWe retrospectively reviewed 924 non-cirrhotic patients with NAFLD presenting to a liver clinic from May 1st 2007 to April 30th 2013. Overweight and obese patients were counseled on lifestyle modifications for weight loss as per USPSTF guidelines. The primary outcome was percent weight change between the first and last recorded visits: % weight change = (weightinitial – weightfinal)/(weightinitial). Baseline BMI and percent BMI change were secondary measures. Predictors of weight loss were determined using logistic regression.ResultsThe mean baseline BMI was 33.3±6.6 kg/m2, and the mean follow-up duration was 17.3±17.6 months. Most patients with NAFLD were in either overweight (26.1%) or class I obesity (30.5%) categories at baseline, while the prevalence of underweight and class III obesity was lower (0.2% and 15.4%, respectively). Overall, there was no change in mean weight or BMI during the follow-up period, and only 183 patients (19.8%) lost at least 5% body weight during the follow up period. Independent predictors of weight loss included number of clinic visits and baseline BMI, and patients with higher baseline BMI required more clinic visits to lose weight.ConclusionsWeight loss is largely unsuccessful in NAFLD patients in the ambulatory care setting. Frequent clinical encounters are associated with weight reduction, especially among individuals with high baseline BMI. Future studies are required to define effective weight loss strategies in NAFLD patients.

Highlights

  • With the rise of obesity and the metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become a major risk factor for both cardiovascular disease and cirrhosis [1]

  • Subjects with NAFLD were identified by ICD-9 codes using the University of Pittsburgh Center for Liver Diseases (CLD) Research Registry, which consists of ambulatory patients with chronic liver diseases presenting to the CLD for long-term care

  • Since the purpose of this study was to determine the effectiveness of routine medical care outside of a clinical trial to encourage weight loss in patients with NAFLD, the providers in the practice were not required to adhere to standardized recommendations for lifestyle modifications

Read more

Summary

Introduction

With the rise of obesity and the metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become a major risk factor for both cardiovascular disease and cirrhosis [1]. NAFLD is an emerging health concern in the developing world; as up to 30% of certain Asian populations exhibit significant steatosis [5]. Hypertension, gender, diet and genetic polymorphisms have been implicated as predictors for the development of NAFLD, the strongest risk factors are insulin resistance and obesity. It has been suggested that NAFLD rates rise with increasing levels of obesity [2,6].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call